A method for resourceful treatment of glutathione bulk drug production wastewater

By converting reduced triphosphonates into salts and separating them by nanofiltration, using iron-carbon microelectrolysis, anaerobic ammonia oxidation, and heterogeneous photo-Fenton treatment, the problems of glutathione resource waste and low pollutant treatment efficiency have been solved, achieving efficient resource recovery and stable degradation, and reducing costs and hazardous waste generation.

CN122403676APending Publication Date: 2026-07-17FUAN PHARM GRP YANTAI JUSTAWARE PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
FUAN PHARM GRP YANTAI JUSTAWARE PHARMA CO LTD
Filing Date
2026-05-14
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing technologies are difficult to efficiently recover glutathione, leading to resource waste. At the same time, the processing costs are high and there is a risk of secondary pollution. Traditional denitrification processes are inefficient and unstable in operation.

Method used

A four-stage synergistic treatment system was constructed by converting reduced triphosphonate into oxidized glutathione, combined with nanofiltration separation, iron-carbon microelectrolysis pretreatment, anaerobic ammonia oxidation coupled with A²/O biochemical treatment, and heterogeneous photo-Fenton deep treatment, to achieve resource recovery and efficient degradation of pollutants.

Benefits of technology

It achieves high-efficiency recovery of glutathione and removal of pollutants, reduces operating costs, reduces the generation of hazardous waste, produces effluent that meets standards and can be reused, and has strong system stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122403676A_ABST
    Figure CN122403676A_ABST
Patent Text Reader

Abstract

本发明公开了一种谷胱甘肽原料药生产废水的资源化处理方法,属于制药废水处理技术领域。该方法包括:预处理与谷胱甘肽还原纳滤回收、铁碳微电解提质、厌氧氨氧化耦合 A² / O 生化脱氮、非均相光芬顿深度处理及絮凝沉淀。通过本发明可实现谷胱甘肽回收率≥85%,氨氮去除率≥98%,铁泥危废减少 90% 以上,最终出水 COD≤50 mg / L、氨氮≤5 mg / L,满足《制药工业水污染物排放标准》及生产回用的要求,具有资源化、高效、低危废、低成本等优点,适合工业化推广应用。
Need to check novelty before this filing date? Find Prior Art